Two of the most closely watched names in AI-driven software, Palantir Technologies Inc. (NASDAQ: PLTR) and UiPath Inc. (NYSE: PATH), are frequently compared by investors trying to identify where the best long-term opportunity lies in the sector.
Both companies are advancing artificial intelligence in meaningful ways, but they operate in distinct parts of the market.
Palantir has built its reputation around large-scale data analytics and decision intelligence platforms, serving government agencies, defense organisations, and major enterprises that require seamless data integration and real-time situational awareness.
UiPath specialises in robotic process automation, using AI to eliminate repetitive tasks and drive operational efficiency across diverse industries.
Palantir’s growth is anchored by its Foundry and Gotham platforms and its Artificial Intelligence Platform, which together enable organisations to process massive datasets and extract real-time insights across defense, intelligence, healthcare, and finance.
Government contracts remain one of Palantir’s most durable revenue sources, with high-profile engagements such as the Department of Defense’s Open DAGIR project highlighting the company’s ability to modernise military operations using AI-driven data tools.
On the commercial side, Palantir has been aggressively expanding through AIP boot camps — hands-on training sessions for prospective enterprise clients — which have proven effective at converting pilot programmes into long-term deployments.
Palantir generated a 24.2% compound annual revenue growth rate from 2021 to 2025, underpinned by rising enterprise and government demand for its analytics capabilities.
Its modular sales approach, which allows clients to adopt individual platform components rather than committing to the full ecosystem at once, has been a key driver of new customer wins and expansion within existing accounts.
The forward-looking numbers reinforce the gap between the two companies.
Consensus estimates point to year-on-year revenue growth of 72% for Palantir in 2026, with earnings per share expected to nearly double, and EPS revisions trending upward over the past 60 days.
UiPath, by contrast, is projected to grow fiscal 2027 sales by 9% with EPS growth of 8%, and estimate revisions have been flat over the same period.
On valuation, UiPath trades at a forward sales multiple of 3.18x, below its 12-month median of 4.08x, while Palantir trades at 36.64x forward sales, also below its historical median of 70.45x.
Both valuations are elevated in absolute terms, but Palantir’s accelerating AI momentum, strengthening enterprise penetration, and sharper estimate revision trend give it the more compelling investment case at present.
Palantir currently carries a Zacks Rank of 2 (Buy), while UiPath holds a Rank of 3 (Hold).
